1-deoxynojirimycin has been researched along with Prediabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Han, A; He, L; Jia, Q; Ren, X; Xing, Y; Xiu, Z; Yang, L | 1 |
| Ampawong, S; Aramwit, P; Fongsodsri, K; Kanjanapruthipong, T; Reamtong, O; Rujimongkon, K; Thaipitakwong, T | 1 |
| Dong, Y; Guo, Q; Han, X; He, X; Jiang, H; Liu, H; Ren, X; Xiu, Z | 1 |
| Davis, SN; Hedrington, MS | 1 |
| Aramwit, P; Rasmi, Y; Supasyndh, O; Thaipitakwong, T | 1 |
| Fuchigami, M; Fukaya, N; Goda, T; Mochizuki, K; Tanaka, Y | 1 |
1 review(s) available for 1-deoxynojirimycin and Prediabetes
| Article | Year |
|---|---|
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Metformin; Prediabetic State | 2019 |
1 trial(s) available for 1-deoxynojirimycin and Prediabetes
| Article | Year |
|---|---|
A randomized controlled study of dose-finding, efficacy, and safety of mulberry leaves on glycemic profiles in obese persons with borderline diabetes.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Blood Glucose; Enzyme Inhibitors; Female; Healthy Volunteers; Humans; Male; Morus; Obesity; Plant Leaves; Postprandial Period; Prediabetic State; Thailand; Young Adult | 2020 |
4 other study(ies) available for 1-deoxynojirimycin and Prediabetes
| Article | Year |
|---|---|
Effect of 1-Deoxynojirimycin on insulin resistance in prediabetic mice based on next-generation sequencing and intestinal microbiota study.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Gastrointestinal Microbiome; High-Throughput Nucleotide Sequencing; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Morus; Prediabetic State; Streptozocin | 2022 |
Mulberry-Derived 1-Deoxynojirimycin Prevents Type 2 Diabetes Mellitus Progression via Modulation of Retinol-Binding Protein 4 and Haptoglobin.
Topics: 1-Deoxynojirimycin; Diabetes Mellitus, Type 2; Haptoglobins; Humans; Inflammation; Insulin Resistance; Morus; Plant Extracts; Plant Leaves; Powders; Prediabetic State | 2022 |
Combinational application of the natural products 1-deoxynojirimycin and morin ameliorates insulin resistance and lipid accumulation in prediabetic mice.
Topics: 1-Deoxynojirimycin; Animals; Diabetes Mellitus, Type 2; Drug Combinations; Flavonoids; Insulin; Insulin Resistance; Lipids; Mice; PPAR gamma; Prediabetic State | 2023 |
Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Topics: 1-Deoxynojirimycin; Animals; Blood Glucose; Cytokines; Drug Evaluation, Preclinical; Enzyme Inhibitors; Gene Expression; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Inflammation Mediators; Leukocytes; Male; Prediabetic State; Rats; Rats, Inbred OLETF | 2011 |